-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CVY7iDpS43E0fqQ/pDaRRr5GMN3RI0S374BvrbndnbB91yqLMXjFKJo0dRE3fx62 S7Pn2W5Aa3OXSpgfnBxudQ== 0000935836-08-000514.txt : 20081114 0000935836-08-000514.hdr.sgml : 20081114 20081114141829 ACCESSION NUMBER: 0000935836-08-000514 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080930 FILED AS OF DATE: 20081114 DATE AS OF CHANGE: 20081114 EFFECTIVENESS DATE: 20081114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KILKENNY CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001133468 IRS NUMBER: 943219916 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06279 FILM NUMBER: 081189792 BUSINESS ADDRESS: STREET 1: 737 NORTH MICHIGAN AVE STREET 2: SUITE 2350 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 3129131250 MAIL ADDRESS: STREET 1: 737 NORTH MICHIGAN AVE STREET 2: SUITE 2350 CITY: CHICAGO STATE: IL ZIP: 60611 13F-HR 1 form13f-hr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2008 Check here if Amendment:___; Amendment Number:___ This Amendment (Check only one. ___ is a restatement. ___ adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Kilkenny Capital Management L.L.C. Address: 737 North Michigan Avenue Suite 737 Chicago IL 60611 Form 13F File Number:28-06279 The institutional investment manager filing this report and the person by whom it is signed hereby represent that all information contained herein is true correct and complete and that it is understood that all required items statements schedules lists and tables are considered integral parts of this Form. Person Signing this Report on Behalf of Reporting Manager: Name: Michael P. Walsh Title: Executive Manager Phone: 312-913-1250 Signature Place and Date of Signing: /s/ Michael P. Walsh Chicago IL November 14, 2008 Report Type (Check only one.: X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report. ___13F NOTICE. (Check here if no holdings reported are in this report and all holdings are reported by other reporting manager(s. ___13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 34 Form 13F Information Table Value Total: 8,535 (X 1000) List of Other Included Managers: Provide a numbered list of the name(s and Form 13F file number(s of all institutional investment managers with respect to which this report is filed other than the manager filing this report. 1 Form 13F File Number: 28-10471 Name: Advantage Advisers LLC NAME OF ISSUER TITLE VALUE SH/ PUT/ INV. OTHER OF CUSIP X SHARES PRN CALL DISC. MGR VOTING AUTH CLASS 1000 SOLE SHR NONE ALTUS PHARMACEUTICALS INC COMMON 02216N105 15 13,872 SH SOLE 13,872 ALTUS PHARMACEUTICALS INC COMMON 02216N105 17 15,565 SH OTHER 1 15,565 CARDIOME PHARMACEUTICAL COMMON 14159U202 417 54,892 SH SOLE 54,892 CORP CARDIOME PHARMACEUTICAL COMMON 14159U202 150 19,686 SH OTHER 1 19,686 CORP CRITICAL THERAPEUTICS COMMON 22674T105 1 6,126 SH SOLE 6,126 CRITICAL THERAPEUTICS COMMON 22674T105 2 10,975 SH OTHER 1 10,975 CUBIST PHARMACEUTICALS COMMON 229678107 110 4,946 SH SOLE 4,946 INC CUBIST PHARMACEUTICALS COMMON 229678107 237 10,669 SH OTHER 1 10,669 INC CUTERA INC COMMON 232109108 103 9,709 SH SOLE 9,709 CUTERA INC COMMON 232109108 210 19,784 SH OTHER 1 19,784 CYPRESS BIOSCIENCES COMMON 232674507 886 120,549 SH SOLE 120,549 CYPRESS BIOSCIENCES COMMON 232674507 301 40,959 SH OTHER 1 40,959 DYAX CORP COMMON 26746E103 328 74,528 SH SOLE 74,528 DYAX CORP COMMON 26746E103 400 90,935 SH OTHER 1 90,935 FOREST LABS COMMON 345838106 1,057 37,361 SH SOLE 37,361 FOREST LABS COMMON 345838106 331 11,700 SH OTHER 1 11,700 GENENTECH INC COMMON 368710406 489 5,519 SH SOLE 5,519 GENENTECH INC COMMON 368710406 203 2,294 SH OTHER 1 2,294 GILEAD SCIENCES INC COMMON 375558103 92 2,007 SH SOLE 2,007 GILEAD SCIENCES INC COMMON 375558103 116 2,536 SH OTHER 1 2,536 INSPIRE PHARMACEUTICALS COMMON 457733103 662 185,417 SH SOLE 185,417 INC INSPIRE PHARMACEUTICALS COMMON 457733103 262 73,473 SH OTHER 1 73,473 INC MEDAREX COMMON 583916101 51 7,858 SH SOLE 7,858 MEDAREX COMMON 583916101 10 1,500 SH OTHER 1 1,500 ONYX PHARMACEUTICALS INC COMMON 683399109 326 9,015 SH SOLE 9,015 ONYX PHARMACEUTICALS INC COMMON 683399109 294 8,119 SH OTHER 1 8,119 PENWEST PHARMACEUTICALS COMMON 709754105 213 103,595 SH SOLE 103,595 CO PENWEST PHARMACEUTICALS COMMON 709754105 119 57,941 SH OTHER 1 57,941 CO PHARMACOPEIA DRUG COMMON 7171EP101 31 20,664 SH SOLE 20,664 DISCOVERY PHARMACOPEIA DRUG COMMON 7171EP101 43 29,041 SH OTHER 1 29,041 DISCOVERY PROGENICS COMMON 743187106 232 17,417 SH SOLE 17,417 PROGENICS COMMON 743187106 166 12,449 SH OTHER 1 12,449 ZYMOGENETICS COMMON 98985T109 456 68,505 SH SOLE 68,505 ZYMOGENETICS COMMON 98985T109 204 30,602 SH OTHER 1 30,602
Q:\EDGAR EasePlus\Kilkenny (Walsh)\9-30-08 13F\form13f.rtf -----END PRIVACY-ENHANCED MESSAGE-----